Lagunamycin, a novel 5-lipoxygenase inhibitor, was isolated from the culture broth of Streptomyces sp. AA0310. This compoundshowed potent rat 5-lipoxygenase inhibitory activity (IC50 6.08 um) without lipid peroxidation.
Streptomyces sp. AA0310. This compoundshowed potent rat 5-lipoxygenase inhibitory activity (IC50 6.08 um) without lipid peroxidation.
As previously described,1~3) a 5-lipoxygenase (5-LPO) inhibitor screen which was composed of a rat 5-lipoxygenase assay and an automated HPLCsystem were successfully employed for analysis of new 5-LPO inhibitory compounds in fermentation broths. In the continued search for 5-LPO inhibitors, Streptomyces sp. AA0310was found to produce a new antibiotic designated lagunamycin. Lagunamycin was produced in good yield by addition of high porous polymer resin in fermentation medium. The active principle was effectively extracted with ethyl acetate from the fermentation broth under acidic conditions and purified by silica gel column chromatography followed by reversed phase silica gel column chromatography. Lagunamycin belonged to a novel family of antibiotics containing a diazo group with potent inhibition against RBL-1 cell's 5-LPO without lipid peroxidation. In this paper, the taxonomy of the producing organism, fermentation, isolation, physico-chemical properties and biological activities of lagunamycin are reported.
Materials and Methods

Taxonomy
Strain AA0310 was isolated from a soil sample collected at College, Laguna, Philippines. The taxonomic studies were carried out mostly according to the procedure of the International Streptomyces Project (ISP) using 16 media as recommended by Shirling and Gottlieb4*, Waksman5) and Arai6). Incubation was carried out at 28°Cfor 27 days. Morphological observations of the culture grown on inorganic salts -starch agar (ISP-4) were recorded with light and scanning electron microscopes. Color assignment was made using the Manual of Color Names (Japan Color Enterprise Co., Ltd., 1987).
Cell wall analysis was performed by the methods of Becker et al.lt8\ Phospholipid and mycolate compositions were determined by the methodsof Lechevalier et al.9' 1 0) and Minnikin et 0/. 1 X), respectively. Menaquinonewas analyzed by the procedure of Collins et al.12) . Fatty acid type was determined by the method of Suzuki et al.13 ). Temperature range for growth was examined on inorganic salts -starch agar (ISP-4) using a temperature gradient incubator TN-3 (Toyo Kagaku Sangyo Co., Ltd.). VOL.46 NO. 6 HPLC Analysis THE JOURNAL OF ANTIBIOTICS 901 A 3-ml portion of the whole broth was extracted with the same volume ofethyl acetate at pH 2.0 and then centrifuged at 3,000 rpm for 15 minutes. The ethyl acetate extract (1 ml) was concentrated to dryness in vacuo. The residue was dissolved in 1 ml of dimethyl sulfoxide and was filtered (Nihon Millipore Kogyo K.K.; FH type; pore size: 0.5/mi). This filtrate (10/d) was analyzed by HPLC on a COSMOSILpacked column (5C1 8-AR; Nacalai Tesque, Inc.) using acetonitrile -water (40 : 60; v/v) at a flow rate of 1.0 ml/minute under monitoring at 254 nm.
Physico-chemical Properties
The IR and UVspectra were determined on a JASCOIR-810 and a UVIDEC-610Cspectrometer, respectively. The XHand 13C NMRspectra were recorded on a JEOLJMN-GX400with CDC13as an internal standard. The MSspectra were obtained with a JEOLJMS-AX505Hmass spectrometer. Elemental analysis was carried out with a Perkin-Elmer 240C Elemental Analyzer.
Sample Preparations
Lagunamycin was dissolved in 10% DMSOin water. The small amount of DMSO(final concentration of 1%) employed as a vehicle had no effect on 5-LPO activity and lipid peroxidation. Epocarbazolin A was also dissolved in 10%DMSO in water.
5-LPO Inhibitory
Assay The assay method employed in this paper was a slight modification of the original procedure of Hook et al}\ RBL-1 cells were grown for 4 days at 37°C and 5% CO2in RPMI1640 minimal essential medium (GIBCO) with 20% heat-inactivated fetal bovine serum (GIBCO). They were harvested by centrifugation and washed twice with 28.5mMPBS, pH 7.0, containing 1 mMEDTA.The cells were resuspended in the same buffer and sonicated. Centrifugation at 13,000 x g yielded the supernatant, which was stored at -80°C as the assay enzyme. For the routine enzymeassay, the thawed supernatant was diluted to a desired specific enzyme activity with 28.5mM PBS containing, l mMEDTA,0.9mM ATP and 0.9mM glutathione. The enzyme dilution (1 10 jj\) was preincubated at 37°C for 2.5 minutes, followed by addition of 5jil of substrate ((2him arachidonic acid plus 25 mMCaCl2 in ethanol -water (3 : 1)). After incubation for 5 minutes the reaction was terminated by addition of 135 jj\ of ethanol, and the solution was centrifuged for removal of precipitated protein. The 5-hydroxyeicosatetraenoic acid (5-HETE) in the supernatant was analyzed by HPLC (Ranin Dynamax C18, i.d. 4.6 x 50mm) with a solvent of 85% methanol in 29.2mM lithium acetate buffer, pH6.3, at a flow rate of 1 ml/minute. Eluate was monitored at 230 nm with a Waters 481 detector and the peak areas were calculated with a Hewlett Packard 3396A integrator.
Iron Dependent Lipid Peroxidation Assay
This assay was performed in a microplate. Reaction mixture (200/il) consisted of 50mMTris-HCl (pH 7.5), 5mMFeSO4 and a test sample. The reaction was started by addition of 1 //g of arachidonic acid and 0.5% -2-thiobarbituric acid. After incubation at 37°C for 3 hours, the absorbance was measured at 540nm.
Antimicrobial activity
Antimicrobial activity of lagunamycin was determined by the serial 2-fold agar dilution method using Nutrient Agar medium (pH 7.0, Eiken). MICs were read in jUg/ml after overnight incubation at 32°C.
Results and Discussion
Taxonomy Morphology Strain AA0310 formed grayish to olive gray aerial mycelia on various agar media. Aerial mycelium formed sprial chains (Spirales; more than 20 spores per chain) and numerous large sclerotia were observed Fig. 1-A) . Scanning electron micrographs show that spores are oblong in shape and O.5~O.7 x O.8~l.O/mi in size with spiny-surface ( Fig. 1-B) . No sporangia and zoospores were observed.
Cultural characteristics
The characteristics of strain AA0310on 16 agar media are summarized in Table 1 . The strain shows good growth on both synthetic and organic media. Mature aerial mycelia are generally powdery. The color of aerial mass is gray to olive gray (Gray color-series).
The colors of vegetative mycelia and colony's reverse sides are reddish black to brownish black. Dark grayish brown, olive or dark brownish gray diffusible pigments are produced in various agar media, but np pH-sensitive. The physiological characteristics and the utilization pattern of carbon sources are listed in Tables 2 and 3 , respectively. Strain AA0310 grows at temperatures from 19 to 39°C with an optimum range from 28 to 33°C.
Chemotaxonomy Analysis of the whole cell hydrolysate of strain AA0310 demonstrated the presence of lldiaminopimeric acid, ribose, glucose and galactose. Accordingly, the cell wall of this strain was classified as type I, whereas the sugar type was uncharacterizable. Phosphatidyl-ethanolamine and mycolic acids were not detected. Analysis of the menaquinone composition revealed 49% MK-9(H6), 40%MK-9(H8) 6% MK-9(H4), 4% MK-9(H10) and 1% MK-9(H2). Thus the fatty acid type is of branched chain 2C (Table4). Erlenmeyer flask is shown in Fig. 2 . A maximumpotency of 1.43mg/ml was achieved in 4 days. Isolation The cultured broth (2.6 liters, pH 7.0) was adjusted to pH 2.0 with 6n HC1 and stirred with ethyl acetate (2 liters) for 2 hours at room temperature. The ethyl acetate layer was separated and concentrated to dryness under reduced pressure at 35°C. The residue was applied onto a silica gel (Kiesel gel 60; 230~400 mesh, Merck) chromatographic column (200 ml). The column was washed first with methylene chloride (1 liter) and then with a mixture ofmethylene chloride -methanol (200 : 1, 1 liter). Active fractions were eluted with a mixture of methylene chloride-methanol (100 : 1, 3 liters) and then concentrated in vacuo. The solid obtained was further applied onto a silica gel column (200 ml). After washing with «-hexane (0.3 liter) and a mixture of rc-hexane-ethyl acetate (4: 1, 1 liter), the column was eluted stepwise with mixtures of «-hexane-ethyl acetate (2: 1 and 1 : 1, each 2 liters). Active fractions were combined and concentrated in vacuo, and the residue was subjected to reversed phase silica gel column chromatography (YMC-ODS-AM 120-S50, YMCCo., Ltd.). The column was developed with a mixture ofacetonitrile -water (3 : 2) and active fractions were evaporated to dryness under reduced pressure to yield a pure yellow powder of lagunamycin (680 mg). It was crystallized from aqueous methanol as yellow needles.
Physico-chemical Properties
Physico-chemical properties are summarised in Table 5 . Lagunamycin is obtained as yellow needles which decomposes at 134~136°C. It was soluble in methanol, acetone and ethyl acetate and insoluble in water. The specific rotation is [a]£6 -33°(c 0.2, MeOH).Color reactions were positive to iodine and sulfuric acid and negative to ninhydrin and Dragendorff reagent. The molecular formula was determined as C19H21N3O4by elementary analysis. The UV spectrum exhibits maxima at 258, 302, 353 (sh) and 420nm in neutral solution and at 233, 264 (sh), 284 and 352nm in alkaline solution. The 400MHzN MR (Fig. 3 ) and 13C NMRspectra (Fig. 4) are shown as more complicated rather than the spectra we expected from its molecular formula. In the course of the structural study, the active principle was pure enough via TLC and HPLCexperiments, therefore the complexity of the NMRsignals was concluded to result from the rotational isomers caused by the bulky side chain against the 3-methyl group of the quinoline plane. The structure of lagunamycin (Fig. 5) will be explained in a separate paper14). Biological Properties Lagunamycin inhibits 5-LPO with an IC50 oi 6.08 jjm, but shows no effect on the lipid peroxidatior (Table 6 ). Carbazomycin B and epocarbazolins A and B which were reported as 5-lipoxygenase inhibitors1' 2*, inhibited not only 5-LPO (IC50:
2.41~4.94fiM) but also lipid peroxidation (IC50; 0.35~20.5^m). The experimental results reveal that the 5-LPO inhibitory activity of lagunamycin doe* not depend on the antioxidative activity like epocarbazolins.
Lagunamycin shows moderate activity against Gram-positive bacteria, but is inactive againsi Gram-negative bacteria as shown in Table 7 . Whentested in mice by intraperitoneal administration 
Discussion
In the continued search for 5-LPO inhibitors from microbial metabolites, carbazomycins1}, epocarbazolins2) and nitrosoxacins3) and nitrosoxacins3) were found to show 5-LPO inhibitory activities.
In addition to the above antibiotics, lagunamycin was found to have a diazo-tetraoxoquinoline nucleus in the molecule. Lagunamycin showed strong 5-LPO inhibitory activities without peroxidation activity. Since desdiazo derivatives of lagunamycin were equipotent to lagnamycin in the 5-LPO assay14), the diazo group in the molecule seems to have no essential roles for 5-LPO activity. Therefore, the current interest is focused on the in vivo anti-chronic skin inflammation activity of this compound.
